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Abstract: 30 
The Arctic and Antarctic share environmental extremes. To survive in such environments, 31 
microbes such as soil fungi need to compete with or protect themselves effectively from other 32 
soil microbiota and to obtain the often scarce nutrients available, and many use secondary 33 
metabolites to facilitate this. We therefore (i) screened for antimicrobial properties of cold-34 
environment Arctic and Antarctic soil fungi, and (ii) identified changes in the secreted 35 
secondary metabolite profiles of a subset of these strains in response to temperature variation. 36 
A total of 40 polar soil fungal strains from King George Island, maritime Antarctic and 37 
Hornsund, Svalbard, High Arctic, were obtained from the Malaysian National Antarctic 38 
Research Centre culture collections. The plug assay technique was used to screen for 39 
antimicrobial potential against Gram-positive and Gram-negative human pathogenic bacteria 40 
(Bacillus subtilis, B. cereus, Pseudomonas aeruginosa, Enterococcus faecalis and 41 
Escherichia coli). About 45% of the tested fungal strains showed antimicrobial activity 42 
against at least one tested microorganism. Three fungal isolates showed good bioactivity and 43 
were subjected to secondary metabolite profiling at different temperatures (4, 10, 15 and 44 
28°C). We observed a range of responses in fungal metabolite production when incubated at 45 
varying temperatures, confirming an influence of environmental conditions such as 46 
temperature on the production of secondary metabolites. 47 
  48 
Keywords: Fungal metabolites, Penicillium flavigenum, Pseudogymnoascus sp., temperature 49 
influence 50 
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1. Introduction 51 
Fungi are remarkable microorganisms known to produce a diverse range of compounds 52 
extracellularly, usually of low molecular weight, known as secondary metabolites (Keller et 53 
al., 2005). Often these secondary metabolites are unique to particular microbial species 54 
(Larsen et al., 2005). There is a general consensus that secondary metabolites are not 55 
essential for growth, development or reproduction, even though they are produced by many 56 
fungi (Madigan et al., 1997). Produced generally near the end of the active growth phase, 57 
these compounds are synthesized from compounds that are themselves derived from primary 58 
metabolic pathways (Davies, 1985). Although their ecological role often remains unclear, 59 
many exhibit antifungal or antimicrobial activity (Peláez, 2006) and are therefore likely to 60 
provide the producing microorganism with a competitive advantage facilitating survival in 61 
their natural environment.   62 
Although the systematic study of fungal secondary metabolites began in 1922 (Raistrick, 63 
1985), it was not until the discovery of penicillin by Alexander Fleming in 1928 (Alharbi et 64 
al., 2014; Ligon, 2004a,b) that the exploration of secondary metabolites started to intensify. 65 
Over recent decades considerable efforts have been devoted to the study of these compounds. 66 
This is, in part, driven by the rapidly increasing levels of resistance towards many of the 67 
currently available antibiotics (Cooper and Shales, 2011). 68 
It is widely accepted that differences in evolutionary pressures have led to some level of 69 
specificity associated with ecological niches (Schutz, 2001). To date, the search for 70 
pharmaceutically-active fungal strains has largely been focussed in the temperate and tropical 71 
regions, and there have been relatively few studies in the cold and stressful environments of 72 
the Arctic and Antarctic. Cold-adapted fungi may provide a valuable and currently untapped 73 
source of novel metabolites. Their survival in the extreme polar environment requires high 74 
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adaptability and resistance against many stresses including low nutrient availability, high UV 75 
radiation and prolonged exposure to both chronic cold and freezing temperatures and short 76 
term thermal maxima during summer (Montiel, 2000; Madronich et al., 1998, Nishiyama, 77 
1977; Des Marais, 1995). Tolerance of these stresses leads to the expectation of evolutionary 78 
adaptations being developed in polar microbes enabling them to remain viable and function at 79 
low temperatures. 80 
Research on extreme environments started to gain momentum the middle of the 20th Century. 81 
Margesin et al. (2007) reported that, by 2007, there were 30,000 studies published on 82 
extremophiles, but also that two-thirds of these studies focused on thermophiles and studies 83 
from cold areas remained rare. Recently, there has been greater emphasis on studies of cold 84 
environment microbes. The production of extracellular cold-tolerant bioactive compounds 85 
and enzymes by polar microbes has been a subject of increasing research interest, particularly 86 
in the context of their potential for biotechnological and pharmaceutical application 87 
(Groudieva et al., 2004; Priscu et al., 1999).  88 
A number of secondary metabolites have been described from Arctic and Antarctic fungal 89 
isolates that exhibit antimicrobial and antifungal activities (e.g. O’Brien et al., 2004). Li et al. 90 
(2008) reported five novel bioactive asterric acid derivatives from an Antarctic ascomycete 91 
(Pseudogymnoascus sp.). Some of these compounds displayed antifungal activity against 92 
Aspergillus fumigatus, and some showed antimicrobial activity against Gram-positive and 93 
Gram-negative bacteria. Penicillium griseofulvum, collected in Greenland, produced a range 94 
of secondary metabolites including griseofulvin, fulvic acid, mycelianamide, roquefortine C, 95 
roquefortine D, chanoclavine I and elymoclavine, all of which contributed to antimicrobial 96 
activity (Frisvard et al., 2004). Niu (2014) reported isolation of new natural products with 97 
unique structural features in Spriromastix sp. from deep sea sediments of the South Atlantic 98 
Ocean.  99 
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Abiotic environmental stresses are particularly important in the terrestrial ecosystems of the 100 
polar regions (Hogg et al., 2006; Tufto, 2000; Convey et al., 2014). Recent rapid changes in 101 
global and regional climates have prompted a range of studies on factors that may influence 102 
microbial interactions in these regions. Chwedorzewska (2010) stated that climate change 103 
may affect polar terrestrial biota via three fundamental factors - temperature, water and solar 104 
irradiance - and small shifts in these factors may result in greater biological impacts. The 105 
recent Climate Change 2014 synthesis report by the Intergovernmental Panel on Climate 106 
Change has predicted an increase of global average temperature likely to be in the range of 107 
0.3°C to 0.7°C for the period 2016 to 2035 and projection for the end of the 21st Century 108 
(2081-2100) likely to exceed 1.5°C, while the polar regions will continue to warm more 109 
rapidly than the global mean (IPCC, 2014). However, the effects of temperature variation on 110 
Antarctic organisms, as elsewhere, have largely not been studied in detail (Convey et al., 111 
2014). A number of temperature manipulation studies, particularly using methodologies such 112 
as Open Top Chambers (OTCs), carried out in recent years have shed some light on the 113 
response of native Antarctic soil arthropod, lichens and plant communities towards elements 114 
of climatic change (Bokhorst et al., 2008, 2011, 2013). Although studies on temperature-115 
driven biodiversity shifts in polar microbial communities are available (Benhua et al., 2014; 116 
Dennis et al., 2012; Newsham et al., 2015), limited data currently exist on the effects of 117 
warming on secondary metabolism in soil microfungal communities.  118 
Clearly one of the primary ecological roles of secondary metabolites is to help the producing 119 
organisms function efficiently in their natural environment (Kliebenstein, 2004) and, often, 120 
their production is influenced by environmental factors (Akula and Ravishankar 2011; 121 
Alvarez et al., 2000). Various studies have examined the effects of external factors such as 122 
temperature, UV-B radiation, soil composition, CO2 and humidity on the production of 123 
secondary metabolites (Abreau and Mazzafera, 2005; Eichholz et al., 2011; Rosa et al., 2001; 124 
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Szakiel and Henry, 2011). Here, we report an initial screening of the antimicrobial properties 125 
of 40 polar soil fungal strains, and examine in detail the influence of temperature on the 126 
overall secondary metabolite production profiles of three of the most active of these strains. 127 
2. Methodology   128 
2.1. Fungal cultivation and maintenance 129 
A total of 40 polar fungal isolates were obtained from the National Antarctic Research Centre 130 
Fungal Collection, held at the University of Malaya, Kuala Lumpur. These fungal strains 131 
were originally isolated from soils collected at different locations in Hornsund, Svalbard 132 
(High Arctic) and King George Island, South Shetland Islands (maritime Antarctic) during 133 
the boreal summer of 2010 and austral summer of 2007/08, respectively. These fungal 134 
isolates had previously been identified using BLAST searches (where sequence data existed) 135 
and/or phylogenetic approaches, including the sequencing of type or voucher specimens. The 136 
available Genbank accession numbers for the identified isolates are provided in 137 
supplementary Table 1.  138 
The 40 fungal strains were cultivated by transferring actively growing mycelia onto potato 139 
dextrose agar plates (PDA; Difco Laboratories, Detroit, MI, USA), with incubation at 4°C. 140 
PDA was prepared by suspending 19.5 g of potato dextrose agar powder in 500 ml of 141 
distilled water and heating with frequent agitation for 1 min to dissolve the powder before 142 
autoclaving at 121°C for 15 min. The autoclaved media was then poured into petri dishes and 143 
allowed to cool. The prepared PDA had a pH of 5.6 ± 0.2. Sub-samples of each strain were 144 
preserved in individual universal bottles containing slants of PDA.  145 
2.2. Bioactivity screening   146 
2.2.2.  Preliminary screening for biological activity 147 
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The antimicrobial activities of all 40 polar fungal isolates were tested in triplicate using the 148 
plug assay technique (Hoskisson at al., 2001; Ezra et al., 2004) against five Gram-positive 149 
and Gram-negative human pathogenic bacteria. The Gram-positive bacteria used were 150 
Bacillus subtilis (Ehrenberg) Cohn. (ATCC 6051), Enterococcus facaellis (Andrewes and 151 
Horder) Schleifer and Kilpper-Balz (ATCC 29212) and B. cereus Frankland and Frankland 152 
(ATCC 11778). The Gram-negative bacteria were Pseudomonas aeruginosa (Schroeter) 153 
Migula (ATCC 27853) and Escherichia coli (Migula) Castellani & Chalmers MTCC 443 154 
(ATCC 25922). All the ATCC standard test human pathogenic bacteria were supplied by the 155 
Microbiology Department, University of Malaya and were maintained on Luria Broth (LB) 156 
agar at 4°C.  157 
Fungal isolates were cultivated on sterile PDA for 14 d prior to carrying out the bioassay, and 158 
bacterial test microorganisms were prepared in liquid suspension to provide a concentration 159 
equivalent of 0.5 McFarland units. Plugs of fungal mycelium growing tangentially to the 160 
edge of the colony were then cut and transferred using a 5 mm cork borer into bacterial-161 
pathogen-seeded Muller Hinton Agar (MHA) plates. Muller Hinton Agar was prepared by 162 
suspending 19g of MHA powder (DifcoTM) in 500 ml of purified water, and the mixture was 163 
then heated with frequent agitation. Next the mixture was autoclaved for 15 min at 122°C. 164 
Once cool enough to handle (45-50°C), it was poured into sterile petri dishes and left to cool 165 
to room temperature. The plates (n = 3 replicates per pathogen) were then incubated at 37°C 166 
for 24 h. After the incubation period inhibition zones were observed and measured. The 167 
degree of toxicity of the fungi on the test microorganisms was determined by the diameter of 168 
the inhibition zone in millimetres (mm). Antimicrobial activities were classified based on the 169 
diameter of the zone of inhibition, with < 7mm considered as no activity, 7-9 mm considered as 170 
weak activity, 9-11 mm as moderate activity and > 11 mm as good activity. Only isolates 171 
with good bioactivity were considered for further analysis.    172 
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The preparation of test pathogens involved streaking each test culture onto Trypticase Soy 173 
Agar (TSA) and incubation overnight at 37°C. Trypticase Soy Agar was prepared by 174 
suspending 20g of TSA powder (DifcoTM) in 500 ml of purified water, then heating with 175 
frequent agitation, and autoclaving for 15 min at 122°C. Once the mixture was cool enough 176 
to handle (45-50°C), it was poured into sterile petri dishes and left to cool to room 177 
temperature. The test-pathogen-streaked TSA plates were incubated overnight at 37°C. After 178 
24 h incubation, 4-5 single colonies were inoculated using a sterile loop into 15 ml universal 179 
bottles containing sterile Mueller Hinton Broth (MHB) and shaken thoroughly. MHB was 180 
prepared by suspending 21g of MHB powder (DifcoTM) in 1L of purified water, and again 181 
heating with frequent agitation, followed by autoclaving for 15 min at 121°C. Once cool 182 
enough to handle (45-50°C), the mixture was poured into 28 ml Universal Bottles and left to 183 
cool to room temperature. The densities of the test pathogens in MHB were matched with 0.5 184 
McFarland standards that were prepared by adding 0.5 ml of 0.048 M BaCl2.2H2O (1.17 % 185 
wt/vol) into 99.5 ml of 0.18 M H2SO4 (1 % v/v). This standard is considered to equate to 1.5 186 
x 108 cfu/ml (Hendrickson and Krenz, 1991). 187 
2.3. Disk diffusion assay  188 
Inhibition of test bacterial growth by the polar fungal strains at different temperatures (4, 10, 189 
15 and 28°C) was measured by the disk diffusion method. All experiments were repeated 190 
three times. Prior to each experiment, two-week-old fungal plugs were transferred into 500 191 
ml conical flasks containing 250 ml PDB and incubated at 4, 10, 15 or 28°C for 21 d. The 192 
cultures were then centrifuged, filtered and extracted with equal volumes of ethyl acetate 193 
(EtOAc). The organic layer was collected and dried using a rotary evaporator and the crude 194 
extract was stored at 4°C until further use.  195 
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The test pathogens were prepared as described above and swabbed onto the surface of MHA 196 
plates. A sterile 6 mm filter disk was loaded with 10 µl of 1mg/mL crude extract and placed 197 
onto the test microorganism seeded plates. As a positive control gentamycin was used and, as 198 
a negative control, the solvent used to dissolve the extracts was included. The plates were 199 
then incubated for 24 h at 37°C. The diameters (mm) of inhibition zones were then measured 200 
and compared across the different incubation temperatures.  201 
2.4. Temperature manipulation studies  202 
Temperature manipulation studies of fungal strains with good bioactivity were carried out 203 
following the in-house protocol MECSUS (Microtiter plate, Elicitors, Combination, Solid 204 
phase extraction, UHPLC, Statistical analysis) (Rasha, 2013) with modifications. MECSUS is 205 
a protocol for microbial metabolite studies that involves miniaturized parallel fermentations 206 
in 96 well plates, parallel extraction and data analysis.  207 
Three fungal strains that showed good bioactivity were selected for micro-scale cultivation at 208 
four different temperatures, 4, 10, 15 or 28°C. Prior to Micro Titre Plate inoculation, fungal 209 
strains were grown in 15 ml Falcon tubes containing sterile 70% Potato Dextrose Broth 210 
(PDB). The growth medium for inoculation was prepared by adding 6 ml of 70% PDB into a 211 
15 ml Falcon tube together with five small steel balls. The Falcon tubes were then covered 212 
with cotton plugs and aluminium foil before being autoclaved at 121°C for 15 min.   213 
Three 5 mm plugs of fungal mycelium were cut out from two-week-old fungal cultures using 214 
a 5 mm cork borer and transferred into separate 15 ml Falcon tubes containing 70% PDB. 215 
Inoculated tubes were then incubated at 4, 10, 15 or 28°C for 14 d. 216 
At the end of 14 d incubation, the tubes containing fungal isolates were transferred into a 217 
biosafety cabinet where the cotton wool packing and aluminium foil cover were replaced 218 
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with sterile screw caps. The closed tubes were then shaken in a Genogrinder® at 1500 rpm for 219 
30 min in order to disrupt the fungal mycelia before cultivation on MT plates.   220 
Cultivation in 2 mL square deep 96-well MTPs involved adding 900 µl of 70% PDB into 221 
each MTP well. The plates were then each covered with a silicon mat, sealed with a custom-222 
made clamp board, and autoclaved. Once the materials were cool enough to be handled, 100 223 
µl of disrupted mycelial solution of each of three fungal strains was pipetted into the MTP 224 
wells. Each fungal strain was assigned individual rows of 12 wells. The MTPs were then 225 
covered with sandwich covers (System Duetz, Germany) and a clamp board before being 226 
incubated at 4, 10, 15 or 28°C for 21 d.  227 
After incubation, the MTP plates were uncovered in a biosafety cabinet, sterile silica SPEX 228 
beads added, and the cultures were then homogenised using a Genogrinder® SPEX® 229 
(SamplePrep, New Jersey) at 1500 rpm for 20 min. This was followed by centrifuging the 230 
plates at 4000 rpm for 30 min to allow the cell debris to settle at the bottom of the wells. 231 
After this, 500 µl of supernatant from the fungal culture from each well of a row 232 
(corresponding to one fungal isolate) was collected in single a sterile glass tube, giving a total 233 
volume of 6 ml (12 wells x 500 µl) per fungal strain. 234 
The collected supernatants were then subjected to extraction with an equal volume of EtOAc. 235 
After shaking, the upper organic layer was transferred into a new and pre-weighed 30 ml vial. 236 
This step was repeated three times and the organic layers were combined. The EtOAc was 237 
evaporated to dryness using a rotary evaporator. The mass of each extract was recorded and 238 
the extracts were then stored at 4°C prior to HPLC analysis.   239 
2.5. HPLC analysis 240 
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Extracts were chromatographically analysed to identify changes in the overall secondary 241 
metabolite profiles obtained at the different culture temperatures. Analytical HPLC was 242 
performed on an Agilent 1260 system (Agilent Technologies, United States) equipped with a 243 
column Synergy 4 µm Hydro-RP 80 Å 150 × 4.6 mm, 4 µm particle size (Phenomenex®, 244 
USA). The HPLC system (Agilent Technologies, United States) consists of the following 245 
components: quaternary pump G1311A, vacuum degasser pump G1322A, auto sampler 246 
G1316A and diode detector (DAD) G1315B. As an internal standard (IS), 1 mL of 1 mg/mL 247 
solution of 4-bromobiphenyl was added to the samples. Samples were prepared by diluting 248 
extracted crude sample of unknown amount into 1 mL of HPLC grade methanol (MeOH). 249 
The IS was then added to the sample. The mobile phase (H2O/water) was prepared by 250 
filtering acetonitrile (ACN) and deionized water on 0.45 µm nylon membrane filters. The 251 
elution gradient was set as follows (solvent B, ACN): 10% at 0 min, 46% at 10 min, 70% at 252 
15 min, 100% at 20 min, 100% at 30 min, 10% at 31 min, equilibration 10 min. The flow rate 253 
was set to 1 ml/min. The injection volume was set at 10 µL. UV-vis data were recorded from 254 
190 to 600 nm and displayed at 220 nm. A Chemstation® chromatography data system 255 
(Agilent Technologies, United States), was used to control the chromatographic system and 256 
process the chromatograms. Chromatographic peaks with intensity > 50 mAU appearing 257 
between retention times (Rt) of 3 and 26 min were considered. The variations in size of major 258 
peaks were computed with reference to the IS. 259 
3. Results and Discussion 260 
3.1. Antimicrobial activity of polar fungi  261 
Forty cold environment soil fungal isolates originating from various habitats were screened 262 
for their antimicrobial properties using the plug assay method against five human pathogenic 263 
bacteria, with their antimicrobial activity being classified according to the extent of the 264 
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inhibition zone produced. Forty-five percent of tested fungal isolates showed antimicrobial 265 
activity against at least one of the five test pathogens. A majority of the fungi tested showed 266 
high inhibition activity against the Gram-positive bacteria, B. subtilis and B. cereus (Table 1), 267 
but only two isolates showed positive activity against the Gram-negative E. coli and P. 268 
aeruginosa. None of the isolates showed activity against E. faecalis. Two fungal strains, 269 
Pseudogymnoascus sp (AK 102 R1-4 sp 5) isolated from King George Island and Penicillium 270 
flavigenum (HND 11 R8-1) isolated from Hornsund, exhibited broad spectrum activity. Of 271 
the five Pseudogymnoascus sp. strains tested, three exhibited good activity. Of four 272 
Penicillium sp. strains tested, three exhibited inhibition.  273 
Most of the fungi tested showed some inhibition activity against Gram-positive bacteria, 274 
comparable to the findings of Nedialkova and Naidenova (2005), who tested antimicrobial 275 
activities in actinomycetes isolated from Antarctica. Previous studies have also indicated that 276 
antibiotic agents of fungal origin most strongly inhibit Gram-positive rather than Gram-277 
negative bacteria (Kumar el al., 2005). The reason for the disparity in the inhibitory activity 278 
between Gram-positive and Gram-negative bacteria relates to differences between the two 279 
groups’ cell wall structures, as Gram-negative bacteria are equipped with a cell wall barrier 280 
that prevents the passage of large molecules and fat-soluble molecules, thus making them less 281 
susceptible to the action of antibiotics in comparison with Gram-positive bacteria (Tortora et 282 
al., 2001). 283 
Two strains in this study displayed activity against both Gram-positive and Gram-negative 284 
bacteria, Pseudogymnoascus sp (AK 102 R1-4 sp 5) and Penicillium flavigenum. (HND 11 285 
R8-1). Pseudogymnoascus sp. showed broad activity against three test pathogens. This fungal 286 
species is commonly encountered in cold environments around the world (e.g. Adams et al., 287 
2006; Singh, 2011), and various Pseudogymnoascus strains have been reported to be endemic 288 
or indigenous to Antarctic and sub-Antarctic regions (Arenz et al., 2006, 2011; Hughes et al., 289 
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2007). This genus belongs to the order Helotiales, which includes typically saprophytic fungi 290 
playing an active role in nutrient recycling. Members of the genus Pseudogymnoascus have 291 
been reported to produce a range of extracellular enzymes including amylase and cellulase 292 
(Krishnan et al., 2014), keratinases (Mercantini et al., 1989), lipase, chinase and urease 293 
(Finotti et al., 1993, 1996). Li et al. (2008) reported that an Antarctic 294 
Pseudogymnoascusstrain exhibited antimicrobial activity against both Gram-positive and 295 
Gram-negative bacteria, consistent with the current study. A study on Antarctic marine fungi 296 
(Henriquez et al., 2014) also confirmed the antimicrobial and antitumoral potential of 297 
Pseudogymnoascus sp.   298 
A second fungal strain identified in the current study that exhibited broad spectrum 299 
bioactivity was the “classic” antimicrobial compound producer Penicillium flavigenum 300 
(HND11 R8-1), isolated from High Arctic Svalbard. Representatives of this genus are 301 
globally distributed and clearly capable of thriving in various ecosystems. Sonjak et al. 302 
(2006) reported that Penicillium species sourced from various habitats showed no or very few 303 
differences in their secondary metabolite profiles. In the current study, isolate HND11 R8-1 304 
exhibited good inhibition activity against both Gram-positive and Gram-negative bacteria, 305 
unlike several other Penicillium strains tested here whose activity was limited to only one 306 
pathogenic bacterium, Bacillus subtilis.  307 
The bryophyte-associated fungus Atradidymella sp. inhibited the growth of Gram-positive 308 
bacteria. This species is also known to be able to infect mosses, and produces soluble 309 
polyphenolic oxidases and cellulases (Davey et al., 2009), but no previous studies have 310 
reported antimicrobial activity.  311 
The three fungal strains mentioned above (Pseudogymnoascussp., Penicillium flavigenum 312 
and  Atradidymella sp. were selected for further temperature manipulation studies to examine 313 
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(a) their overall secondary metabolite production profiles at different temperatures, and (b) 314 
their antimicrobial activity at different temperatures assessed via a disk diffusion assay. 315 
3.2. Temperature influence on secondary metabolite production profile 316 
Inspection of chromatograms and determination of the relative concentrations of major 317 
compounds with reference to an internal standard revealed an overall increase in compound 318 
concentrations for the major peaks at 4°C for Atradidymella sp. The other two isolates, 319 
Pseudogymnoascus sp. and Penicillium flavigenum, differed with higher concentrations 320 
obtained at 15°C. An overall reduction of concentrations produced by all strains was 321 
observed at 10°C (Figure 1 a, b, c). These data confirm that culture temperature influences 322 
the production of secondary metabolites in all three tested fungal strains, although not in a 323 
simple fashion.  324 
Environmental stressors such as temperature, ultra-violet radiation, water availability, 325 
salinity, pH, micronutrient and water availability, and CO2 concentration are important 326 
factors that affect the physiology and metabolic pathways of fungi (Magan, 2007). These 327 
factors play crucial roles in determining microbial community composition in soils (Castro et 328 
al., 2010) and small shifts in these abiotic factors could have significant effects on the growth 329 
and productivity of key microorganisms (Bell, 2013). Although the above-mentioned 330 
environmental factors often do not act independently in polar soil ecosystems (Peck, 2006),   331 
temperature is a critical environmental variable that affects soil ecology in the polar regions 332 
(Convey et al., 2014), and seasonally changing temperatures influence the relative abundance 333 
of microorganisms (Bell, 2013). Temperature is an important environmental factor that 334 
influences physiological function of all organisms. This is particularly the case for 335 
microorganisms as they are poikilotherms whose temperature follows that of their external 336 
environment. Temperature variation in any given habitat is a natural phenomenon, taking 337 
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place over various timescales from the immediate and dynamic, through diurnal to seasonal 338 
and longer, and these variations can have important impacts on the survival and evolution of 339 
microorganisms (Convey et al., 2014; Davey et al., 1992; Peck et al., 2006). In polar soils, 340 
microbial activities have been demonstrated at temperatures as low as -15°C (Steven, 2007). 341 
Significant effects of microbial competition on biogeochemical flux were observed over the 342 
summer where warmer temperatures led to an increase in overall activity (Bell, 2013). In the 343 
current study, we have demonstrated that culture temperatures clearly affect the production of 344 
secondary metabolites in the three polar soil fungal strains examined in more detail, but clear 345 
and consistent patterns did not emerge and the fungal responses were complex, as also noted 346 
by Shohael (2006).  347 
3.3 Effects of temperature on antimicrobial activity 348 
Microorganisms, particularly soil-dwelling fungi, are known to produce a number of 349 
secondary metabolites with antimicrobial properties as a defence mechanism, thought to aid 350 
in competition for resources (Gallo et al., 2004), and temperature has also been reported to 351 
exert a profound effect on the antimicrobial production and activity of fungi (Himabindu and 352 
Jetty, 2006). Castro (2010) demonstrated a substantial increase in antagonistic activity 353 
between many Arctic soil bacterial isolates with increased temperature, proposing two 354 
possible explanations: 1) increased production of antimicrobials or, 2) shifts in relative 355 
growth rates. In the current study the antimicrobial activities of the selected 356 
Pseudogymnoascus  sp. strain tested varied at different temperatures (Table 2). After crude 357 
extraction for the disk diffusion assay, the extracts obtained from incubations at 4°C or 15°C 358 
inhibited four of the five tested human pathogens (E. coli, B. subtilis, S. aureus and C. 359 
albicans). The widest diameters of the zones of inhibition, inferred to indicate the greatest 360 
activity, were observed for extracts from cultures incubated at 15°C (Table 2). Only two test 361 
organisms (B. subtilis and C. albicans) were inhibited at 10°C. All extracts were able to 362 
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inhibit the yeast C. albicans, although the diameter of the zone of inhibition reduced with 363 
increasing temperature.  364 
Three of the five test microorganisms were inhibited by Penicillium flavigenum crude 365 
extracts obtained at 10 and 15°C. At 4°C two test microorganisms were inhibited and at 28°C 366 
only C. albicans was inhibited. S. aureus was only inhibited by the crude extracts produced at 367 
10 and 15°C. P. aeruginosa and E. coli were not inhibited by any of the crude extracts. 368 
Although the ability to produce compounds that inhibited the test organisms appeared to be 369 
retained over a wide range of culture temperatures, when exposed to the highest experimental 370 
temperature the inhibitory ability reduced dramatically. 371 
All crude extracts obtained from cultures at 10°C showed moderate biological activity (Table 372 
2). Good inhibitory activity was visible at 4 and 28°C for Pseudogymnoascus sp. and 373 
Atradidymella sp. The crude extract of P. flavigenum exhibited moderate activity across all 374 
culture temperatures. This suggests that the responses of the fungi tested here to temperature 375 
were species-specific. More detailed studies of the optimal growth conditions and production 376 
of secondary metabolites, along with formal identification of specific metabolites, of each of 377 
these strains are required to further understand the relationship between growth dynamics and 378 
secondary metabolite production at different temperatures.  379 
4. Conclusions 380 
This study investigated the antimicrobial properties of 40 cold-adapted soil fungi from the 381 
Arctic and Antarctic. The data obtained showed that 45% of tested fungal cultures expressed 382 
at least some antimicrobial activity towards at least one of the five human pathogenic bacteria 383 
tested. Pseudogymnoascus sp., P. flavigenum and Atradidymella sp. showed the strongest 384 
antimicrobial activity. These taxa are found abundantly in polar soils and have also been 385 
reported to exhibit antifungal activities and produce cold-adapted enzymes, consistent with 386 
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active roles in decomposition and nutrient recycling in the soil ecosystem. Our study provides 387 
further confirmation that these species are rich producers of extracellular substances. Culture 388 
temperature clearly influenced the production of secondary metabolites, including 389 
compounds with antibacterial activity, in Pseudogymnoascus sp., Penicillium flavigenum and 390 
Atradidymella sp. Further genomic and functional analyses of interspecific competition and 391 
synergistic interactions in polar soil microbial communities are required to help identify the 392 
effects of climate variability and warming on soil ecosystems.   393 
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Table 1. Bioactivity of fungal isolates against five test microorganisms. 
 
Strain code 
Test microorganism 
 
Bacillus 
subtilis 
 
Escherichia 
coli 
Bacillus 
cereus 
Pseudomonas 
aeruginosa 
Escherichia 
faecalis 
AK07KGI102 R2-3 - - +++ - - 
AK07KGI 301 R2-2 ASCO 6 ++ - - - - 
AK07KGI 102 R2-3 SP 1 - - +++ - - 
AK07KGI 105 R3-2 SP 17 - - - - - 
AK07KGI 1001 R1-1 SP 2 - - - - - 
HND 10 R2-4 + - - - - 
HND 9 R1-1 SP 34 + - - - - 
HND 11 R2-2 SP 36 + - - - - 
HND 10R1-3 + - - - - 
HND 5 R5-3 - - - - - 
HND 2 R8-2 - - - - - 
HND 1 R7-2 - - - - - 
HND 4 R7-3 ++ - - - - 
AK07KGI 102 R1-4 SP 5 +++ - ++ +++ - 
AK07KGI 102 R3-3 SP 30 - - +++ - - 
AK07KGI 102 R3-1 SP 16 - - - - - 
AK07KGI 1001 R3-2 SP 1 ++ - - - - 
AK07KGI 105 R3-1 - - - - - 
HND 12 R8-1 SP 5 - - - - - 
HND 2 R5-3 - - - - - 
HND 1 R7-3 - - - - - 
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AK07KGI 102 R2-1 SP 18 ++ - - - - 
HND 7 R1-1 - - - - - 
HND 5 R6-2 - - - - - 
AK07KGI 103 R2-1 + - - - - 
HND 7 R6-3C - - - - - 
AK07KGI 102 R1-3 ASCO 2 ++ - - - - 
AK07KGI 102 R3-2 ASCO 4 - - - - - 
HND 11 R8-1 +++ +++ ++ ++ - 
HND 2 R5-4 +++ - - - - 
HND 4 R5-1 - - - - - 
AK07KGI 101 R2-3SP 1 - - - - - 
AK07KGI 101 R3-1 SP 2 - - - - - 
AK07KGI 1001 R2-1 - - - - - 
AK07KGI 102 R3-1 SP 2 - - - - - 
HND 12 R2-1 - - - - - 
AK07KGI 1001 R1-1 SP 4 ++ - - - - 
HND 12 R8-2(2) - - - - - 
AK07KGI 102 R1-4 SP 16 - - - - - 
AK07KGI 2001 R2-1 SP 1 - + - - - 
 
     * Activities are classified as: - = no activity, weak activity = (+), moderate activity = (++), 
high activity = (+++). 
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Table 2. Antimicrobial activity of Atradidymella sp., Pseudogymnoascus sp., and Penicillium 
flavigenum crude extracts measured at different temperatures. 
Isolates Test organisms mean  ± standard deviation diameter of inhibition zone 
(mm)  
at different culture temperatures  
4°C   10°C 15°C 28°C 
HND 10 
(Atradidymella sp.) 
 
 
 
E. coli 0.0 7.0 ± 0.5 7.0 ± 1.0 0.0 
B. subtilis 0.0 0.0 6.0 7.0 ± 0.5 
S. aureus 15.0 ± 0.5 9.0 ± 0.5 7.0 ± 1.0 9.0 ± 1.73 
P. aeruginosa 0.0 0.0 0.0 0.0  
C. albicans 11 .0 13.0 ± 0.5 15.0 15.0  
AK 102 
(Pseudogymnoascus 
sp.) 
E. coli 23.0 ± 1.7 0.0 24.0 ± 1.5 0.0 
B. subtilis 16.0 ± 1.0 6.0 ± 0.5 17.0 ± 1.7 7.0 ± 0.5 
S. aureus 13.0 ± 1.7 0.0 18.0 ± 1.3 16 .0± 1.7 
P. aeruginosa 0.0 0.0 0.0 0.0 
C. albicans 18.0 ± 0.5 10.0 ± 0.5 18.0 8.0 
HND 11 
(Penicillium 
flavigenum) 
E. coli 0.0 0.0 0.0 0.0 
B. subtilis 7.0 7.0 ± 1.5 7.0 0.0 
S. aureus 7.0 8.0 ± 1.0 7.0 ± 1.5 0.0 
P. aeruginosa 0.0 0.0 0.0 0.0 
C. albicans 8.0 7.0 ± 1.6 7.0 7.0 
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Strain ID Collection 
Location 
Thermal class (Genebank 
Accession no) 
Identity 
AK07KGI 102 R2-1 
SP18 
King George 
Island 
Psychrophillic KY646431 Pseudorotium.sp 
AK07KGI 2001 R2-
1 SP1 
King George 
Island 
Psychrophillic KY646433 Pseudogymnoascus.sp 
AK07KGI 102 R1-4 
SP5 
King George 
Island 
Psychrotolerant KY623481 Pseudogymnoascus.sp 
AK07KGI 1001 R3-
2 SP 1 
King George 
Island 
Psychrophillic KY646435 Pseudogymnoascus.sp 
AK07KGI 105 R3-2 
SP17 
King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 103 R2-1 King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 102 R2-3 
ASCO 2 
King George 
Island 
Psychrophillic KY646438 Penicillium commune 
AK07KGI 101 R2-
3SP 1 
King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 102 R3-3 
SP 30 
King George 
Island 
psychrotolerant n/a n/a 
AK07KGI 301 R3-3 
SP2 
King George 
Island 
psychrotolerant KY646432 Pseudogymnoascus.sp 
AK07KGI 102 R1-4 
SP16 
King George 
Island 
Psychrotolerant KY646441 Tausonia pullulans 
AK07KGI 301 R2-2 
ASCO 6 
King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 101 R3-1 
SP 2 
King George 
Island 
Psychrophillic KY623479 Leuconeurospora.sp 
AK07KGI 102 R3-1 
SP 2 
King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 102 R3-2 
ASCO 4 
King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 1001 R1-
1 SP4 
King George 
Island 
Psychrophillic n/a n/a 
AK07KGI 102 R2-3 
SP1 
King George 
Island 
Psychrotolerant KY623480 Penicillium commune 
AK07KGI 1001 R1-
1 SP2 
King George 
Island 
Psychrophillic KY646437 Pseudgymnoascus.sp 
AK07KGI 1001 R2-
1 
King George 
Island 
Psychrophillic KY646434 Pseudogymnoascus.sp 
AK07KGI 105 R3-1 King George 
Island 
Psychrophillic KY646436 Pseudogymnoascus.sp 
AK07KGI 102 R3-1 
SP 16 
King George 
Island 
Psychrotolerant KY646440 Tausonia pullulans 
HND11 R8-1 Hyrneodden 
peninsula, 
Mariesletta, 
Hornsund 
Psychrophillic KY623482 Penicillium flavigenum 
HND10 R2-4 Hyrneodden 
peninsula, 
Psychrotolerant KY934270 Atradidymella sp 
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Mariesletta, 
Hornsund 
HND2 R5-4 Hyettevika,Hornsu
nd 
Psychrophillic n/a n/a 
HND5 R6-2 Ralstranda, 
Hornsund 
Psychrophillic KY646429 Isafaria farinosa 
HND5 R5-3 Ralstranda, 
Hornsund 
Psychrophillic KY623484 Isafaria farinosa 
HND2 R8-2 Hyettevika,Hornsu
nd 
Psychrophillic KY646428 Isafaria farinosa 
HND2 R5-3 Hyettevika,Hornsu
nd 
Psychrophillic KY646439 Penicillium flavigenum 
HND1 R7-2 North-western 
slopes of 
Kvartsittknattane, 
Hornsund 
Psychrophillic KY646430 Phialocephala sp. 
HND12 R8-1 SP 5 Hyrneodden 
peninsula, 
Mariesletta, 
Hornsund 
Psychrophillic KY646427 Isaria farinosa 
HND7 R6-3 North-western 
slopes of 
KvartsittknattaneH
ornsund 
Psychrophillic n/a n/a 
HND4 R5-1 Revdalen, 
Hornsund 
Psychrophillic KY623483 Tausonia pullulans 
HND4 R7-3 Revdalen, 
Hornsund 
Psychrophillic n/a n/a 
 
HND11 R2-2 SP 36 Hyrneodden 
peninsula, 
Mariesletta, 
Hornsund 
Psychrotolerant n/a n/a 
HND9 R1-1 SP 34 Hyrneodden 
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Psychrotolerant n/a n/a 
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Figure 1 a. Changes in relative concentrations of major secondary metabolite peaks produced 
by Atradidymella sp. at 4, 10, 15 and 28°C. 
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Figure 1 b. Changes in relative concentrations of major secondary metabolite peaks produced by 
Pseudogymnoascus sp. at 4, 10, 15 and 28°C. 
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Figure 1 c. Changes in relative concentrations of major secondary metabolite peaks produced 
by Penicillium flavigenum at 4, 10, 15 and 28°C. 
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